A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its experimental drug for a rare kidney disease successfully passed a Phase 3 trial, a key step in the company’s journey to diversify beyond its main cystic fibrosis drugs. The Boston-based drugmaker said Monday …
Continue reading “The Vertex kidney drug povetacicept is profitable within the examine for IgAN”









